Point72 Asset Management
KIN

Point72 Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Point72 Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,620,476
Closed -$14.9M – 1318
2021
Q2 		$14.9M Sell
1,620,476
-2,229,724
-58% -$13M 0.07% 355
2021
Q1 		$19.1M Buy
+3,850,200
New +$18.6M 0.09% 275

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Point72 Asset Management's KIN Position: Q3 2021 in Review

Point72 Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,620,476 shares — an estimated $14.9M sold.

Point72 Asset Management first reported a position in KIN in Q1 2021 and held it in 2 quarters. The position peaked at $19.1M in Q1 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Point72 Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Point72 Asset Management sold 1,620,476 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $14.9M.
  • Point72 Asset Management first reported a position in Kindred Biosciences, Inc. in Q1 2021 and held it in 2 quarters.
  • Point72 Asset Management's Kindred Biosciences, Inc. position peaked at $19.1M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Point72 Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.